Objective: Acute lung injury still accounts for postoperative mortality after cardiopulmonary bypass (CPB). The safety and the efficacy of pulsatile pulmonary perfusion (PPP) during CPB were analyzed. Preliminary results of the first PPP trial in human beings are reported. Methods: Thirty low-risk coronary artery bypass grafting (CABG) patients were prospectively randomized to receive PPP with oxygenated blood during CPB and aortic cross-clamping (15 patients, PPP-group) or to conventional CPB (15 patients, control group). Alveolo-arterial oxygen gradient (A-aDO 2 ) was set as the primary end point and collected preoperatively, at intensive care unit (ICU) arrival (T1), 3 h postoperatively (T2), and post extubation (T3). Secondary end points were collected at the same time points and consisted of respiratory indices (partial pressure of arterial oxygen/fraction of inspired O 2 (PaO 2 /FiO 2 ), lung compliance, mixed-venous partial pressure of oxygen ( pO 2 )) and hemodynamic pulmonary parameters (indexed pulmonary vascular resistances (PVRI), pulmonary arterial pressure (PAP), pulmonary capillary wedge pressure (PCWP), and cardiac index (CI)). Bronchoalveolar lavage (BAL) fluid was collected preoperatively, at ICU arrival (T1-BAL) and after 4 h. Results: There were no PPP-related complications. Patients undergoing PPP showed a better preserved AaDO 2 (group-p = 0.001) throughout the study period (group Â time-p = 0.0001). PaO 2 /FiO 2 and lung compliance were better preserved by PPP (group-p and group Â time-p 0.05 for all). Pulmonary hemodynamic status was positively influenced by PPP, as shown by the higher CI (group-p = 0.0001, group Â time-p = 0.0001), and the lower PVRI, PAP, and PCWP (group-p 0.001, group Â time-p = 0.0001 for all). Postoperative BAL specimens demonstrated a lower absolute count of white blood cells (group-p = 0.0001), a higher percentage of monocytes/macrophages (group-p = 0.027), and a lower percentage of neutrophils (group-p = 0.015) after PPP. Conclusions: Oxygenated blood PPP proved safe and significantly ameliorated pulmonary hemodynamic parameters and respiratory indices in low-risk CABG. #
Introduction
The etiology of pulmonary dysfunction after cardiac surgery is multifactorial [1] [2] [3] [4] . However, contact of blood with artificial surfaces, lung ischemia/reperfusion injury, and cardiopulmonary bypass (CPB)-induced non-physiologic linear perfusions -out of multiple potential etiologies causing acute lung injury -are considered the main causes of the dysfunction [1] [2] [3] [4] . Recent studies analyzing the potential benefits of pulmonary perfusion on lung ischemia/reperfusion injury, and of pulsatile pulmonary perfusion (PPP) on linear-flow-related inflammatory response, have seen contradictory results [1] [2] [3] [4] [5] [6] [7] [8] . Indeed, most of the studies on PPP were from animals, with obvious limitations when translated into clinical practice [2, 9] . Moreover, quite different protocols were employed to perfuse the lungs, thus making overall interpretation of data difficult and uncertain [1, 5, [7] [8] [9] [10] [11] .
Therefore, it was the aim of this study to investigate the role of PPP with the patient's own oxygenated blood during CPB and aortic cross-clamping, focusing on the safety of the procedure as well as on the respiratory outcome after isolated elective coronary artery bypass grafting (CABG). To the best of our knowledge, this is the first study investigating PPP in humans.
Materials and methods
The study was set to evaluate the safety and the effects of PPP during CPB in terms of hemodynamic response, respiratory function, and cytological infiltration at bronchoalveolar lavage (BAL). To minimize the potential bias resulting from different confounding factors encountered in daily clinical practice, strict enrollment criteria were defined. Accordingly, from November 2008 to November 2010, 30 patients undergoing elective, first-time, isolated, low-risk (logistic EuroSCORE (European System for Cardiac Operative Risk Evaluation) 5%), three-vessel CABG were prospectively enrolled. Exclusion criteria were: age > 70 years, logistic EuroSCORE > 5%, emergent/urgent/salvage procedures, left-ventricular ejection fraction < 50% and/or left-ventricular end-diastolic pressure (LVEDP) >15 mmHg at preoperative echocardiography, associated cardiac or vascular surgical procedures, redo surgery, preoperative intraaortic balloon pump (IABP) assistance, diabetes, obesity (body mass index (BMI) > 30 kg m À2 ), smoking, chronic obstructive pulmonary disease (COPD) or other lung diseases, pulmonary hypertension, renal disease (Kidney Disease Outcome Quality Initiative (KDOQI) class !2), previous irradiation, previous thoracic surgery, previous transfusion (within 6 months), recent (30 days) infections, liver dysfunction, ongoing steroids therapy, alcoholic dependency/drug abuse, neurologic dysfunction, acquired/congenital deficit of the immune system, auto-immune diseases, and cancer.
For the purpose of investigating the safety and the efficacy of PPP, all those complications with the potential to interfere with pulmonary and/or cardiac function were accounted as adverse events and the patient excluded from the overall functional analysis. In particular, the following post hoc exclusion criteria were predefined: a persistently increased (more than 1 h) LVEDP/PCWP >25% of the preoperative data and/or a persistently reduced (more than 1 h) CI 1.4 l min À1 m À2 during the intensive care unit (ICU) stay, despite titration of inotropic support on the hemodynamic monitoring and adequate correction of preload and all electrolyte and blood gas abnormalities, need for preoperative/postoperative IABP, perioperative acute myocardial infarction, >2 units of red packed cells transfusion, >600 ml of fresh-frozen plasma transfusion, any platelet transfusion, re-operation for bleeding, pneumothorax, and pleural effusion requiring drainage in the ICU, were considered criteria to withdraw the patient from the ongoing study. Perioperative acute myocardial infarction was defined by any of the following criteria: (1) new Q waves of >0.04 ms with a peak Troponin I (TnI) >3.7 mg l À1 or TnI concentration >3.1 mg l À1 at 12 h postoperatively; (2) >25% reduction in R waves in at least two leads on electrocardiography (ECG) associated with the above-mentioned TnI peaks; and (3) new akinetic or dyskinetic segments at echocardiography. In case of post hoc withdrawal of patients, should any perioperative complication have occurred, that complication would have been further investigated and any chance to establish a link with PPP considered.
The study protocol was approved by the institution's Ethical Committee/Institutional Review Board, and an informed consent was obtained for all patients. On admission at our Institution, patients were randomized by lottery, drawing preprepared sealed envelopes containing the group assignment. This pilot study enrolled 30 patients until November 2010. Accordingly, 15 patients (PPP-group) were allocated to receive PPP with oxygenated blood, while other 15 patients were assigned to undergo conventional CPB without PPP (control group, C-group).
Anesthesia and ICU care
All patients underwent Swan-Ganz catheter insertion through the right internal jugular vein, for continuous hemodynamic monitoring, at the time of anesthetic induction. Postoperative chest roentgenogram on ICU admission was routinely obtained to confirmed appropriate position. Anesthesia was standardized: anesthetic induction consisted of intravenous propofol infusion at 2 mg kg À1 combined with fentanyl administration at 0.10 mg kg À1 . Propofol infusion (150-200 mg kg À1 min À1 ) and isoflurane (0.8% inspired concentration) maintained anesthesia in the operating room. Neuromuscular blockade was achieved by 4 mg h À1 vecuronium bromide, and lungs were ventilated to normocapnia with a volume-controlled ventilation, at a frequency of 12 per minute, a tidal volume of 8 ml kg À1 , and a fractional concentration of oxygen in the inspired air (FiO 2 ) of 0.5. A positive end-expiratory pressure (PEEP) was set at 5 cmH 2 O. During CPB, mechanical ventilation was discontinued. Starting with CPB weaning, a 30-s recruiting maneuver was performed and standard ventilation reestablished. The recruiting maneuver was standardized and consisted of three periods of manual sustained inflation, lasting 30 s each, at a pressure of 40 cmH 2 O. The Evita-4 ventilator (Evita 4 Drager Medizintechnik GmbH; Lubeck, Germany) was used for mechanical ventilation and for the assessment of lung compliance at different time points (see Section 2.3). The lungs were then ventilated mechanically for at least 4 h after termination of surgery, with PEEP maintained at 5 cmH 2 O during the entire study period. FiO 2 and ventilation rates were adjusted to keep partial pressure of arterial oxygen (PaO 2 ) > 100 mmHg and PaCO 2 between 30 and 35 mmHg. Airway clearance was maintained by means of routine tracheal suctioning. Depth of anesthesia was controlled with bispectral index measurements (Philips BIS W Quattro Sensor, Aspect Medical Systems, Inc.) and was maintained < 40 during surgery and for the first 4 h of ICU stay. Weaning from mechanical ventilation started after the 4th hour since ICU admission, provided hemodynamic stability by invasive measurements with no or only low-dose inotropic support (dopamine or dobutamine < 3.5 mg kg À1 min À1 ) and no ECG evidence of myocardial ischemia, acid-base balance, chest drainage < 80 ml h À1 , PCWP below 15 mmHg, and a body temperature of 36 8C. A negative preliminary neurological exam and patient co-operation were considered a mandatory prerequisite to proceed with mechanical ventilation weaning.
Surgery
Surgery was always performed through median sternotomy, by the same senior surgeon (FS). The left internal mammary artery was always harvested, through an open pleural space, in a pedicled fashion and used as an in situ graft on the left anterior descending coronary artery. The saphenous vein (SV) was used to complete revascularization. Proximal anastomoses of all SV grafts were constructed on the ascending aorta after aortic declamping, by means of a side-biting clamp.
Management of CPB was standardized. Heparin was given at a dose of 300 IU kg À1 to achieve a target activated clotting time of 480 s or above. Blood recovery with an autotransfusion device (Autotrans Dideco, Mirandola, Modena, Italy) was performed intra-operatively in all cases. A level of hemoglobin lower than 8 g dl À1 prompted blood transfusion. A standard CPB circuit was used, which included a Sorin phosphorylcholine-coated tubing set (Sorin Group SpA, Milano, Italy), a Jostra roller pump (Jostra, Maquet Cardiopulmonary, Hirrlingen, Germany), and a hollow-fiber membrane-coated oxygenator that incorporated also a 40-mm filter (Sorin Synthesis TM , Sorin Group Spa, Milano, Italy). The extracorporeal circuit was primed with 1400 ml of Ringer's lactate solution and 40 mg of heparin.
A non-pulsatile systemic CPB flow was established at 2.4 l min À1 m À2 . All patients were cooled to moderate hypothermia ranging from 32 to 34 8C. Cardiac arrest and myocardial protection were accomplished by means of aortic cross-clamping coupled with intermittent antegrade and retrograde hyperkalemic cold blood cardioplegia (1:4 ratio), as reported by Buckberg et al. [12] . Blood gas management during CPB was directed toward maintenance of pH at 7.35-7.40 and PaCO 2 at 35-40 mmHg. PaO 2 was maintained higher than 200 mmHg. Blood gas management was conducted according to the principle of alpha-stat management. In the PPP-group, PPP using the patient's own oxygenated blood at a flow rate of 7 ml kg À1 min À1 was initiated at the start of CPB, and terminated at the beginning of the weaning period. The pulmonary flow was infused into the main pulmonary artery via a 14-Fr cannula (Edwards Fem-Flex, Edwards Lifesciences, Irvine, CA, USA) and drained out the left atrium through a vent, positioned through the right superior pulmonary vein, to secure a bloodless surgical field and a decompressed left ventricle. Pulsatility was achieved by using a pulsatile pump (Jostra, Maquet Cardiopulmonary, Hirrlingen, Germany) integrated in the CPB machine, at a rate of 60 bpm, according to the protocol suggested by the manufacturer. By contrast, standard CPB without any pulmonary perfusion was carried out in the control group. Heparin was neutralized with protamine sulfate at the end of CPB in all patients.
End points
The primary end point of the study was to evaluate the critical role of PPP on gas exchange by measuring A-aDO 2 . The alveolo-arterial oxygen gradient (A-aDO 2 ) was calculated as follows:
A-aDo 2 , and lung compliance (LC)) were measured at the same time points, except for T3, which was set immediately before extubation for only LC. All the other respiratory indices were considered secondary end points. Pulmonary hemodynamic parameters were also secondary end points and consisted of: indexed pulmonary vascular resistances (PVRI), mean pulmonary arterial pressure (PAP), pulmonary capillary wedge pressure (PCWP), and cardiac index (CI). Other systemic parameters were collected and analyzed: mean arterial pressure (MAP), central venous pressure (CVP), fluid balance (FB), and hemoglobin. All the hemodynamic parameters were continuously monitored from the Swan-Ganz catheter with the Vigilance System (Edwards Lifesciences, Irvine, CA, USA), and collected, as well as FB and hemoglobin, at the same four time points as for the respiratory indices. Fluid balance was defined as the net gain/loss resulting from I.V. infusions/transfusions versus diuresis/perspiration/blood loss.
A bronchoalveolar lavage (BAL) was also performed preoperatively after intubation (T0), at ICU arrival (T1) and after 4 h (T2), as described by Schlensak et al. [13] The processing and analyzing of the BAL fluid was identical for both groups. The cells were counted in a hemocytometer after cytocentrifugation and hematoxylin-eosin staining. Absolute white blood cell (WBC) count and the corresponding percentage of neutrophils, monocytes/macrophages, lymphocytes, and eosinophils were reported.
Finally, clinical outcome (mortality, morbidity, intubation time, in-ICU and in-hospital lengths of stay, incidence of respiratory insufficiency needing non-invasive positive-pressure ventilation, acute renal insufficiency and failure) was collected and it was considered, from a statistical point of view, as descriptive only. In-hospital mortality was defined as any death occurring during hospital stay or in the first 30 postoperative days. Hospital morbidity was defined as any complication requiring specific therapy or causing a delay in ICU or hospital discharge. Intubation time was considered starting from ICU admission. Acute respiratory insufficiency needing non-invasive positive-pressure ventilation (NIV) was diagnosed, if patients had at least one of the following parameters: respiratory acidosis (arterial pH 7.35 with PaCO 2 ! 45 mmHg); arterial O 2 saturation by pulse oxymetry < 90% or PaO 2 < 60 mmHg at FiO 2 ! 0.5; respiratory frequency > 35 per minute; decreased consciousness, agitation, or diaphoresis; clinical signs suggestive of respiratory muscle fatigue, and increased work of breathing such as the use of respiratory accessory muscles, paradoxical motion of the abdomen, or retraction of the intercostal spaces. Acute renal insufficiency was defined as >50% increase over the preoperative serum creatinine value, acute renal failure as acute renal insufficiency requiring renal replacement therapy. Low output state (LOS) was diagnosed, if the patient demonstrated hemodynamic compromise or a CI persistently (>1 h) lower than 1.4 l min À1 m À2 during the ICU stay, despite inotropic support and adequate correction of preload and all electrolyte and blood gas abnormalities. Inotropic support was recorded, and defined as low dose (dopamine or dobutamine < 3.5 mg kg À1 min
À1
), medium dose (dopamine or dobutamine >3.5 but <5 mg kg À1 min
), or high dose (dopamine or dobutamine >5 mg kg À1 min À1 and/or epinephrine or norepinephrine at any dose).
Statistical analysis
Between-within interactions of 4-time A-aDO 2 measurement, with a partial eta squared of 0.351 and a calculated effect size f of 0.735 in 15 patients for each study arm resulted in a power (1-beta error probability) of 99% with an alpha-error probability of 0.05 (G Power 3.0.10, Kiel, Germany).
Pre-and perioperative data were summarized as mean and standard deviation (SD) or median and 25th-75th percentile if continuous, and as counts and percent if categorical. Continuous variables were tested for normality with the Kolmogorov-Smirnov test and compared between the two treatment groups (PPP-group vs Control group) with the Student's t-test or the Mann-Whitney U test, accordingly. Categorical variables were compared with the Fisher's exact test. Ordinal variables were also compared with MannWhitney U test. Repeated measures analysis of variance (ANOVA) was used to compare serial data related to the respiratory function, the systemic and pulmonary hemodynamic status, and the cytological data from BAL. Reported p values include group-p, assessing level of difference between groups; time-p, assessing change over time of measured variables; and group Â time-p, assessing group-time interaction. Comparisons were considered significant if p < 0.05. Statistical analysis was performed by the Statistical Package for Social Sciences (SPSS) program for Windows, version 15.0 (SPSS, Inc., Chicago, IL, USA).
Results
The two groups proved comparable for baseline and intraoperative variables (Table 1 ). All patients survived the operation, without intra-operative mortality. There were neither perioperative acute myocardial infarctions, nor reoperation for bleeding. No patient was withdrawn from the ongoing study because of any of the above-mentioned exclusion criteria.
Respiratory indices
When respiratory indices were considered, A-aDO 2 significantly worsened at T1 and T2 in both groups, showing a slight recovery at T3 (time-p = 0.0001, Table 2 ). However, PPP-group was associated with a better preservation of AaDO 2 compared with controls (group-p = 0.001; group -Â time-p = 0.0001). Similarly, both groups showed a progressive decline of postoperative oxygenation index (PaO 2 / FiO 2 ) at T1 and T2, which partially ameliorated at T3 (timep = 0.0001, Table 2 ). However, such decline was attenuated in PPP-group (group-p = 0.007; group Â time-p = 0.05). Despite pvO 2 values showing a progressive but minimal decline in the early postoperative period since T1, such difference was not significant between the two groups, or across the two groups over time (group-p = 0.930; group -Â time-p = 0.614, Table 2 ). Finally, LC declined after surgery in both groups, lasting until T3 (time-p = 0.0001). Such decline was higher in C-group (group-p = 0.05; group Â timep = 0.05, Table 2 ).
Hemodynamic parameters
Comparable inotropic support was registered in the two groups (no inotropic support: PPP-group 7/15, 46.7% vs C- The two groups also showed similar systemic MAP (groupp = 0.510), CVP (group-p = 0.100), circulating hemoglobin levels (group-p = 0.963), and fluid balances (groupp = 0.709); similarly, the modifications over time (throughout the study period) of all these variables were comparable between the two groups (group Â time-p = NS for all, Table  3 ).
When hemodynamic pulmonary parameters were considered, PPP induced a significant amelioration of CI, PVRI, PCWP, and PAP. In particular, PPP resulted in a better preserved CI throughout the study period (group-p = 0.0001, group Â time-p = 0.0001, Table 4 ), together with lower PVRI (group-p = 0.0001, group Â time-p = 0.0001, Table 4 ). PAP proved lower during the whole study period whenever PPP was employed (group-p = 0.0001, group Â time-p = 0.0001), and correlated with a lower PCWP (group-p = 0.001, group -Â time-p = 0.0001, Table 4 ).
BAL
When BAL was considered, profound changes developed after surgery, as shown in Table 5 . In particular, absolute WBC count significantly augmented after surgery (timep = 0.0001), but remained always lower across the study period whenever PPP was employed (group-p = 0.0001, group Â time-p = 0.0001). Moreover, the cytology of BAL changed significantly over time. As a result of the absolute WBC augmentation, all the populations (neutrophils, monocytes/macrophages, eosinophils, and lymphocytes) augmented with time (time-p = 0.0001 for all), but PPP was associated with a significantly higher infiltration of monocytes/macrophages (group-p = 0.027) compared with controls (Fig. 1, panel C) , in whom a significantly higher infiltration of neutrophils was detected (group-p = 0.015; Fig. 1, panel B) . Moreover, these changes were maintained over time (group Â time-p = NS for both, Table 5 ). On the other hand, no differences were detected between the two groups in terms of percentage of lymphocytes or eosinophils (group-p = NS and group Â time-p = NS for both). To facilitate the interpretation of the results, these percentages are plotted in Fig. 1 (inset panel A) . Signs of activation (vacuolization) of monocytes/macrophages were detected in both groups (Fig. 1, inset panel C) . One patient (6.7%; p = 1.0) in each group developed transient (<15 min) marginal LOS requiring augmentation of the inotropic support. These patients were not withdrawn from the study because of the transient nature of the LOS. One patient in C-group (6.7% vs 0% in PPP-group, p = 1.0) developed transient acute renal insufficiency and respiratory insufficiency needing NIV. However, all the postoperative complications completely recovered, and all patients were discharged in overall healthy conditions. Therefore, no patient was withdrawn from the study up to date, based on the above-mentioned exclusion criteria.
Clinical outcome

Discussion
The etiology of pulmonary dysfunction after cardiac surgery is thought to be the result of several combined effects [1] . These include extra-CPB factors (general anesthesia, sternotomy, postoperative pain with hypoventilation, breach of the pleura, surgical wound-related inflammatory response, etc.) and intra-CPB factors (blood contact with artificial materials, loss of arterial physiologic pulsation, lung ischemia/reperfusion, pulmonary air and/or fat embolism, hypothermia, lung ventilatory arrest, etc.) [1] [2] [3] [4] . The combination of all these variables result in both a local (lung) and a systemic inflammatory response, mediated by endothelial cells, leukocytes, complement, cytokines, chemokines, and other soluble molecules, all of which contribute to perioperative lung damage [1, 2] . Overall, the contact of blood with artificial surfaces of the CPB circuit, the lung ischemia/reperfusion injury, and the intra-operative CPB-associated non-physiologic linear perfusion are thought to play the major role in triggering the pulmonary and systemic inflammatory response [1] [2] [3] [4] . Indeed, despite the fact that the 'contact mechanism' can be attenuated by heparin-coated circuits or other more innovative biosurfaces, it is ultimately considered, at least to some extent, unavoidable [1] . On the other hand, different researchers have tried in the past decades to reduce both the lung ischemia/reperfusion injury, by means of pulmonary perfusion during CPB, and the linear-flow-associated lung inflammation, by means of 'pulsatile' pulmonary perfusion systems, reaching contradictory results [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] , also in view of the large application of animal models.
Pulmonary blood flow during total CPB is limited to the bronchial artery [3, 8] . On the other hand, the lungs are the only organs receiving the entire cardiac output in physiolo- gical instances, being therefore highly susceptible to the ischemic injury and to the ischemia/reperfusion mechanism of damage [8] . In this study, we confirmed a better preservation of lung function, in terms of either functional respiratory indices or pulmonary hemodynamic parameters with PPP. Schlensak et al. had already demonstrated that lung ischemia resulted in significant augmentation of alveolar septal thickness, together with a significant reduction of the alveolar surface area after CPB, all of which caused postoperative impairment of oxygenation [13] . Accordingly, these ultrastructural and functional changes improved with pulmonary perfusion [13] . In line with these results, we have found a significant amelioration of A-aDO 2 and PaO 2 /FiO 2 , demonstrating a better gas exchange and oxygen delivery at the alveolo-arterial barrier in the PPP-group versus control. Our data confirmed also previous literature findings, showing an improved oxygenation whenever the antegrade pulmonary perfusion was employed, regardless of the use of different oxygenators [2, 6, 8, 9] , or of the subject's own lungs [3, 14] . Moreover, the comparable pvO 2 during the entire perioperative period between the two groups excluded a hemodynamic pulmonary impairment (i.e., a different degree of perfusion, responsible for a ventilation/ perfusion unbalance, between the two groups) [15] . Indeed, to the best of our knowledge, despite different studies that showed better results with the application of pulmonary perfusion [2, 3, 6, 8, 9] , no one excluded the risk for such a bias. Similarly, the comparable MAP, circulating hemoglobin levels, CVP, and fluid balances further attenuate the risk for potential confounding factors, related either to an altered ventilation/perfusion or to a different degree of iatrogenic edema of the lung parenchyma [1, 8, 9] . As Asimakopoulos et al. demonstrated, postoperative lung injury is characterized also by the inflammatory-induced interstitial and alveolar edema, with epithelial damage and elastic fiber fragmentation, which induces the rapid activation of pulmonary fibrosis [16] . Alveolar capillary leakage was further confirmed by Sievers showing higher alfa2-macroglobulin levels in BAL of patients receiving standard CPB [6] . Kowalski et al. found an inverse correlation between lung perfusion and the lung wet-to-dry ratio after reperfusion [17] . The lung compliance subsequently altered, resulting in a restrictive respiratory insufficiency [16] . Therefore, the reduction of pulmonary inflammation already reported with pulmonary perfusion during CPB [8, 10] , further resulted in the amelioration of perioperative lung compliance, as also shown by our study, which reported a significant higher decline in LC in the C-group.
In our experience, all the respiratory indices worsened compared with the preoperative values regardless of the PPP, further demonstrating that other complex mechanisms contribute to postoperative lung dysfunction. Accordingly, a recent article by Groeneveld et al. showed a key role of surgical trauma, transfusions, and atelectasis on postoperative lung injury [18] . To this regard, however, except for the pulmonary perfusion strategy, the two groups in our study can be considered comparable for surgical approach, ventilation strategies, and transfusion requirements, thus minimizing the potential confounding effects of these factors. From a histological point of view, in CPB-associated lung injury, neutrophils appear to play a significant role. After the administration of protamine, the neutrophil count in the pulmonary artery exceeds the count in the systemic arterial blood, suggesting that neutrophils maybe prone to be sequestrated in the lungs [16] . Other studies confirmed that concentrations of neutrophils in BAL were higher after CPB in comparison with controls [19] , and the role of pulmonary macrophages, activated monocytes, and monocyte-secreted pro-inflammatory cytokines on lung inflammation and dysfunction has been increasingly recognized [16] . Monocytes are known to migrate out of the pulmonary vessels into the lung interstitial and alveolar space, where they may be transformed into macrophages during pulmonary inflammation [20] . Alveolar macrophages are activated within 30 min of acute lung injury, and it has been suggested that, after the onset of ischemia/reperfusion lung injury, activated lung macrophages secrete chemoattractants for monocytes and neutrophils, which activate and infiltrate the lung tissue [16] . Schlensak et al. already reported a significant elevation of neutrophils in BAL fluid of animals, as early as at the end of CPB, which was attenuated by pulmonary perfusion [13] . Sievers et al. found elevated levels of leukocyte-derived elastase, a strong predictor of the onset of acute lung injury, in the BAL fluid of patients, who did not undergo pulmonary perfusion [6] . Siepe et al. analyzed lung biopsies of pigs undergoing PPP, and found a significantly lower tissue inflammation whenever PPP was employed [2] . We also confirmed a significantly higher inflammation in BAL fluid of patients belonging to C-group, in terms of a switch toward a higher neutrophils and a lower monocytes/macrophages evidence. Indeed, the reduced percentage of neutrophils and the higher percentage of macrophages in BAL fluids after PPP should not be considered unequivocally beneficial: as already reported, all previous studies have failed to demonstrate a complete protection of the lungs after pulsatile perfusion, but only showed an attenuation of the post-CPB related inflammatory damage [2, 6, 18] . Asimakopoulos et al. stressed the important role of macrophages in initiating the ischemia/ reperfusion injury [16] . Similarly, we demonstrated here the constant presence of activated (vacuolized) macrophages also in BAL from PPP patients (Fig. 1) , possibly suggesting an alternative inflammatory pathway when pulmonary perfusion is employed, as already prompted by other authors [13] . Furthermore, the role of surgical trauma on lung inflammation has been well recognized [18] . We can consequently speculate that other factors, pre-existing to CPB, might trigger an initial mechanism of lung damage, which could be then exacerbated by the subsequent ischemia/reperfusion injury induced by standard CPB, or attenuated by PPP. Furthermore, other factors (anesthesia, ventilation during the weaning phase, transfusions, etc.) during the remaining intra-operative and postoperative time-course might further impact the level of lung infiltration by WBCs, as also suggested by the lost of any difference between the two groups at T2-BAL.
Finally, we were able to demonstrate a beneficial effect of PPP on pulmonary hemodynamic status, already at the earliest post-CPB time point (T1). Although this result was lost thereafter, possibly due to the limited number of patients enrolled, there is a trend toward a beneficial pulmonary vasodilation also at T2 and T3 (as demonstrated by the lower PAP values). Given the beneficial effects on right ventricular afterload, it is not surprising that the whole cardiac performance -as indirectly inferred by CI and PCWP -was improved by PPP.
Although the lower CI found in C-group might partly explain the worse respiratory outcome observed in the same cohort, the reciprocal interaction between cardiac and respiratory function in the postoperative period remains quite difficult to assess, knowing that 'lung outcome' is a function of both overall ventilation and perfusion [1, 2, [13] [14] [15] [16] [20] [21] [22] .
It has been demonstrated since the early 1980s that ischemia/reperfusion injury of the lungs induces pulmonary vasoconstriction [20] . Two cornerstone articles further demonstrated that CPB-induced impairment of endothelial pulmonary nitric oxide (NO) production was mediated by the complement-leukocyte system, and was responsible of the postoperative pulmonary vasoconstriction and right ventricular dysfunction [21, 22] . Given the beneficial role of PPP on neutrophil infiltration and pulmonary inflammatory damage, as shown at BAL, our study demonstrate also an 'antiinflammatory'-mediated pulmonary vasodilation with PPP during CPB. These data confirmed those of Chai et al., who showed lower pulmonary vasoconstriction during partial CPB with antegrade pulmonary flow compared with standard full CPB [14] . A vasodilative effect of pulmonary perfusion with venous blood was also reported by Serraf et al., despite the fact that these authors did not prevent, with their experimental model, any post-CPB dysfunction (except the achievement of a pulmonary vasodilation), possibly because of the low oxygen tension of the employed solution [23] .
The topic of oxygen content during pulmonary perfusion/ reperfusion is still a matter of debate: Bolling et al. demonstrated [24] , with 'oxygenated' pulmonary reperfusion after total CPB, a direct leukocyte-mediated and oxygen-mediated lung injury, which could be reduced by leukocyte-filtration. Indeed, this study employed also highflow pulmonary reperfusion [24] . On the other hand, a recent study by Kagawa et al. proved the importance of low-flow ( 10 ml kg À1 min À1 ) pulmonary reperfusion to prevent CPBmediated lung injury compared with high-flow (>20 ml kg À1 min À1 ) protocols, as that of Bolling et al. [24, 25] . We can thus speculate that the beneficial effects of our PPP on pulmonary hemodynamic parameters can be also attributed to the low-flow regimen (7 ml kg À1 min À1 ) of our experimental protocol. Furthermore, our 'timing' of PPP, aimed at preventing the onset of ischemia/reperfusion lung damage, rather than reducing the lung injury at reperfusion, may also help to explain the efficacy of hyper-oxygenated blood of our strategy, in contrast to Kagawa et al., who found detrimental effects with hyper-oxygenated blood, when used to reperfuse an already ischemic lung after CPB [25] . Certainly, more studies aimed at analyzing the role of oxygen tension and flow rate of pulmonary perfusate on pulmonary hemodynamic are necessary to further clarify these topics.
Therefore, we conclude that our preliminary study of PPP in humans demonstrated a protective effect of PPP on CPBinduced lung damage, clinically manifested by better preserved respiratory indices and pulmonary hemodynamic parameters, further confirmed by a shift toward a lower infiltration of neutrophils at BAL fluid analysis.
Limitations of the study
The main limitation of the study is related to its preliminary nature and to the small sample size of patients enrolled. This is a result of the single-center design of the project, which, on the other hand, guarantees uniformity of the perioperative management of the patient population throughout the experimentation. Moreover, on an intentionto-treat basis, we adopted strict enrollment criteria, to minimize potential confounding factors and misleading results. Furthermore, patients were operated on by the same senior surgeon (FS), and underwent the same CPB led by the same perfusionists, thus reducing the risk of human biases. To the best of our knowledge, this is the first prospective, randomized study investigating the role of PPP in humans.
The results of the present study, however, should be carefully interpreted and certainly mandate future investigations, especially in different subsets of patients, such as high-risk CABG, patients with pre-existing pulmonary comorbidities, etc.
Future studies analyzing the optimal pulmonary flow, the best oxygen content of blood used for PPP, and/or the role of different strategies of mechanical ventilation during CPB to maximize the ventilation/perfusion ratio (e.g., low volumes with high rates, low rates with high volumes, presence/ absence of PEEPs, and so on) should be encouraged.
topic of growing interest in our community. We share this enthusiasm in Bristol and are performing a few clinical and experimental studies in this area.
On reading your manuscript, the obvious conclusion appears to be that pulmonary perfusion appears to be a safe thing to do with no obvious detrimental effect to the patient. I have two constructive comments leading to two simple questions.
The rationale for using pulmonary perfusion is to avoid pulmonary ischemia and reperfusion injury as you have highlighted. To this end, I was a little bit disappointed to see that in the methodology used for your study there was no direct measurement of oxidative stress and markers of ischemia. My first question is, was there any specific reason for not using more appropriate specific markers of lung ischemia/reperfusion injury?
Dr Santini: As you mentioned, this is a pilot study. The first task was to demonstrate its feasibility, and that is what we have done so far.
As an ongoing study, there are some variables that we are going to collect. These regard inflammatory molecules and signs of oxidative stress as you mentioned, which are not available as yet. But we have been collecting samples of blood, first from the left atrium immediately after the reperfusion phase, and so we will be expecting those results.
Dr Ascione: The second question is really a comment about the technique proposed.
According to the manuscript, pulmonary perfusion was started on going on cardiopulmonary bypass. And at that time ventilation was discontinued, which basically means that the lungs were left open to air and therefore fully collapsed. So this was a pulmonary perfusion in the context of fully collapsed lungs.
There is evidence suggesting that with fully collapsed lungs, the use of pulmonary perfusion is still associated with jeopardized alveolar oxygenation due to proximal shunting.
So I guess I am saying that you might still have a degree of alveolar ischemia despite using pulmonary perfusion just because you are perfusing collapsed lungs. Did you give any consideration to this potential limitation in this study?
Dr Santini: I agree. I think the operation sometimes is, more difficult if you have a lot of stuff in the field, and also the ventilated lung, may represent a problem.
We may speculate that ventilation during perfusion might have provided better results but both groups had the same treatment, so they were not ventilated.
I do not think that this variable really would impact on the final result. Dr Ascione: Maybe a very quick final point. It might be informative for those who have interest in this technique.
You said you used 7 ml/kg/min continuous perfusion. Did you have a predefined range of perfusion pressure? Did you stick to a perfusion pressure as we would do for instance when we protect the heart? Dr Santini: We measured volume continuously, and we also have a flow meter on the outflow of the pulsatile Jostra pump. But we continuously measure just volume. We did not measure pressure.
7 ml/kg/min is a low volume compared to the extensive field that you are going to perfuse, so it is very difficult to achieve differences in pressure.
